Evidence map›Paper›PMID 32717723›Full record

ArticleAging2020

Circular RNA DHX33 promotes malignant behavior in ccRCC by targeting miR-489-3p/MEK1 axis.

Jie Wang, Jian-Qiu Zhang, Xiao-Lei Zhao, Jing-Yu Lu, Ze-Ming Weng, Zhen-Min Ding, Feng-Qiang Yang

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Role of Circular RNA in Kidney-Related Diseases.Frontiers in pharmacology · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jie WangDepartment of Urology, Ninghai First Hospital, Zhejiang 315600, China.
Jian-Qiu ZhangDepartment of Urology, Ninghai First Hospital, Zhejiang 315600, China.
Xiao-Lei ZhaoDepartment of Urology, Huaihe Hospital of Henan University, Kaifeng 475000, China.
Jing-Yu LuDepartment of Anesthesia, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Ze-Ming WengDepartment of Urology, Ninghai First Hospital, Zhejiang 315600, China.
Zhen-Min DingDepartment of Anesthesia, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Feng-Qiang YangDepartment of Urology, Ninghai First Hospital, Zhejiang 315600, China.
Shanghai Tenth People's Hospital · CNShanghai East Hospital · CNHenan University Huaihe Hospital and Huaihe Clinical Institute · CNNinghai First Hospital Medicare and Health Group · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mounting evidence indicates that circular RNAs modulate the initiation of clear cell renal cell carcinoma (ccRCC). However, their specific roles in the malignancy of ccRCC is understudied. Here, we present a novel circular RNA, circDHX33, that is up-regulated in ccRCC cell lines and tissues. Upregulated circDHX33 in ccRCC patients significantly correlates with advanced TNM stage and metastasis. Suppressing circDHX33 expression inhibits the proliferation and invasion of cultured cells, and suppresses tumor growth

Indexed as

Carcinoma, Renal CellDEAD-box RNA HelicasesDisease ProgressionGene Expression Regulation, NeoplasticHumansKidney NeoplasmsMAP Kinase Kinase 1MicroRNAsNeoplasm StagingRNA, CircularSignal TransductionTumor Cells, CulturedUp-RegulationDEAD-box RNA HelicasesDHX33 protein, humanMAP2K1 protein, humanMAP Kinase Kinase 1MicroRNAsMIRN489 microRNA, humanRNA, CircularcircDHX33clear cell renal cell carcinomaMEK1miR-489-3p

Identifiers

PMID32717723
PMCPMC7425503
OpenAlexW3045574023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.